i-spero® benefits from a clinical investigation initiated in five European countries to determine both clinical and cost effectiveness. The study follows over 900 patients using i-spero® for up to a year in order to determine the positive impact on:
If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.